The Health Innovation Trailblazer Awards Academic had been awarded to the head of Biogem Stem and Tissue Regeneration research laboratory, as part of the third edition of the 'UAE International Genomics Awards', held at the end of May in the Emirati city. The significant contribution potentially offered to the future of medicine by Professor Falco has been recognized, with particular reference to his studies and experiments on organoids, aimed at strengthening the preclinical activity in the field of oncological and genetic pathologies. The award, delivered by the geneticist Maryam Matar (the first Emirati woman to hold the position of general director in the Government of her country) and by Sheikh Nahyān bin Mubarak Al Nahyan (former Minister of Scientific Research of the Emirates), ideally involves all the group of Professor Falco and his research activities, focused on the role of molecular mechanisms associated with stemness in oncological processes.

''Particular attention – specifies Falco – has always been paid by us to tumor progression and drug resistance, with the aim of improving the reliability of preclinical models in the development of pharmacological therapies, with an evolution which, starting from the in vitro study, has led us to the development of preclinical models in vivo, and lately ex vivo, through the use of organoids for the enhancement of personalized therapies''.

''The award just received - Falco finally says - will be a further stimulus for Biogem's research activities which, in the near future, will focus on technological transfer (bringing laboratory data to clinical practice in a short time) and on the ability to identify the patient's needs in the diagnostic and pharmacological field".